Posted On: 03/13/2014 12:53:21 AM
Post# of 60
Latest Pacific Biosciences of California (PACB) Headlines
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 10, 5:09PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
31.8% Return Seen to Date on SmarTrend Pacific Biosciences of California Call (PACB)
Comtex SmarTrend(R) - Fri Mar 07, 4:56PM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ
ACB) on December 16th, 2013 at $5.06. In approximately 3 months, Pacific Biosciences of California has returned 31.82% as of today's recent price of $6.67.
PacBio, the Post-Hype Sleeper of Genomics
Luke Timmerman, The Motley Fool - Motley Fool - Mon Mar 03, 1:22PM CST
Hype and biotech go hand in hand, but genomics takes exaggeration up a few extra notches . When genomics companies fail, they tend to crash especially hard. Yet every now and then, a company that is monumentally hyped falls flat and then figures out...
Pacific Biosciences of California Has Returned 43.7% Since SmarTrend Recommendation (PACB)
Comtex SmarTrend(R) - Fri Feb 21, 9:38AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQACB) on December 16th, 2013 at $5.06. In approximately 2 months, Pacific Biosciences of California has returned 43.68% as of today's recent price of $7.27.
Pacific Biosciences (PACB) Jumps: Stock Moves 8.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:46AM CST
Pacific Biosciences was a big mover last session, with shares rising over 8%.
4 Biotech Stocks Under $10 to Watch
at The Street - Tue Feb 18, 1:30PM CST
Keep these under-$10 biotech stocks trading on unusual volume on your radar.
Pacific Biosciences of California Up 25.1% Since SmarTrend Uptrend Call (PACB)
Comtex SmarTrend(R) - Thu Feb 06, 4:48PM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQACB) on December 16th, 2013 at $5.06. In approximately 2 months, Pacific Biosciences of California has returned 25.10% as of today's recent price of $6.33.
Why Pacific Biosciences of California Shares Cratered
Alex Planes, The Motley Fool - Motley Fool - Wed Feb 05, 3:28PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Pacific Biosciences of California have...
Pacific Biosciences of California, Inc. Announces Fourth Quarter 2013 Financial Results
GlobeNewswire - Tue Feb 04, 9:49PM CST
Pacific Biosciences of California, Inc. (NasdaqACB) today announced financial results for the fourth quarter ended December 31, 2013.
Pacific Biosciences of California Shares Up 44.7% Since SmarTrend's Buy Recommendation (PACB)
Comtex SmarTrend(R) - Thu Jan 30, 10:59AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQACB) on December 16th, 2013 at $5.06. In approximately 2 month, Pacific Biosciences of California has returned 44.66% as of today's recent price of $7.32.
Why Inteliquent, Pacific Biosciences of California, and Galectin Therapeutics Are Today's 3 Best Sto
Sean Williams, The Motley Fool - Motley Fool - Tue Jan 21, 4:15PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. With the Martin Luther King Jr. holiday shortening the trading...
Pacific Biosciences of California (PACB) Surges: Stock Moves 14.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 21, 8:21AM CST
Pacific Biosciences of California, Inc. (PACB) was a big mover last session, as the company saw its shares rise by over 14% on the day.
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 10, 5:09PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
31.8% Return Seen to Date on SmarTrend Pacific Biosciences of California Call (PACB)
Comtex SmarTrend(R) - Fri Mar 07, 4:56PM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ
ACB) on December 16th, 2013 at $5.06. In approximately 3 months, Pacific Biosciences of California has returned 31.82% as of today's recent price of $6.67. PacBio, the Post-Hype Sleeper of Genomics
Luke Timmerman, The Motley Fool - Motley Fool - Mon Mar 03, 1:22PM CST
Hype and biotech go hand in hand, but genomics takes exaggeration up a few extra notches . When genomics companies fail, they tend to crash especially hard. Yet every now and then, a company that is monumentally hyped falls flat and then figures out...
Pacific Biosciences of California Has Returned 43.7% Since SmarTrend Recommendation (PACB)
Comtex SmarTrend(R) - Fri Feb 21, 9:38AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ
ACB) on December 16th, 2013 at $5.06. In approximately 2 months, Pacific Biosciences of California has returned 43.68% as of today's recent price of $7.27. Pacific Biosciences (PACB) Jumps: Stock Moves 8.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Feb 19, 8:46AM CST
Pacific Biosciences was a big mover last session, with shares rising over 8%.
4 Biotech Stocks Under $10 to Watch
at The Street - Tue Feb 18, 1:30PM CST
Keep these under-$10 biotech stocks trading on unusual volume on your radar.
Pacific Biosciences of California Up 25.1% Since SmarTrend Uptrend Call (PACB)
Comtex SmarTrend(R) - Thu Feb 06, 4:48PM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ
ACB) on December 16th, 2013 at $5.06. In approximately 2 months, Pacific Biosciences of California has returned 25.10% as of today's recent price of $6.33. Why Pacific Biosciences of California Shares Cratered
Alex Planes, The Motley Fool - Motley Fool - Wed Feb 05, 3:28PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Pacific Biosciences of California have...
Pacific Biosciences of California, Inc. Announces Fourth Quarter 2013 Financial Results
GlobeNewswire - Tue Feb 04, 9:49PM CST
Pacific Biosciences of California, Inc. (Nasdaq
ACB) today announced financial results for the fourth quarter ended December 31, 2013. Pacific Biosciences of California Shares Up 44.7% Since SmarTrend's Buy Recommendation (PACB)
Comtex SmarTrend(R) - Thu Jan 30, 10:59AM CST
SmarTrend identified an Uptrend for Pacific Biosciences of California (NASDAQ
ACB) on December 16th, 2013 at $5.06. In approximately 2 month, Pacific Biosciences of California has returned 44.66% as of today's recent price of $7.32. Why Inteliquent, Pacific Biosciences of California, and Galectin Therapeutics Are Today's 3 Best Sto
Sean Williams, The Motley Fool - Motley Fool - Tue Jan 21, 4:15PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. With the Martin Luther King Jr. holiday shortening the trading...
Pacific Biosciences of California (PACB) Surges: Stock Moves 14.4% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jan 21, 8:21AM CST
Pacific Biosciences of California, Inc. (PACB) was a big mover last session, as the company saw its shares rise by over 14% on the day.
(0)
(0)
